| Chun H Auyeung, OD | |
|
5576 Norbeck Rd Unit B, Rockville, MD 20853-2408 | |
| (301) 238-7199 | |
| (301) 977-4664 |
| Full Name | Chun H Auyeung |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 12 Years |
| Location | 5576 Norbeck Rd Unit B, Rockville, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073878476 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 0618002162 (Virginia) | Secondary |
| 152W00000X | Optometrist | TA2316 (Maryland) | Primary |
| Provider Name | Miller Eyecare Olney, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366507303 PECOS PAC ID: 5799871638 Enrollment ID: O20071023000604 |
News Archive
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 4 days ago
| Provider Name | Hyattsville Optometry, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1174884126 PECOS PAC ID: 3971750142 Enrollment ID: O20120822000493 |
News Archive
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 4 days ago
| Provider Name | Vc Insight, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1326551367 PECOS PAC ID: 5496019846 Enrollment ID: O20180510001999 |
News Archive
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chun H Auyeung, OD 5576 Norbeck Rd Unit B, Rockville, MD 20853-2408 Ph: (301) 238-7199 | Chun H Auyeung, OD 5576 Norbeck Rd Unit B, Rockville, MD 20853-2408 Ph: (301) 238-7199 |
News Archive
Salmonella bacteria research from two recent NASA space missions discovered key elements of the bacteria's disease-causing potential that hold promise for improving ways to fight food-borne infections on Earth.
A recent study by a Saint Louis University researcher confirms findings that about half of the U.S. population has a version of a gene that causes them to metabolize food differently, putting them at greater risk of developing diabetes.
Researchers at University of California, San Diego School of Medicine have received a five-year, $9.5-million award from the National Institute of Allergy and Infectious Diseases at the National Institutes of Health to establish an interdisciplinary center to define the systems biology of antibiotic resistance. The program will be led by Bernhard Palsson, PhD, Distinguished Professor of Bioengineering and Pediatrics, and Victor Nizet, MD, professor of pediatrics and pharmacy.
Novartis announced today that the US Food and Drug Administration has approved Kymriah (tisagenlecleucel) suspension for intravenous infusion, formerly CTL019, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia (ALL) that is refractory or in second or later relapse.
› Verified 4 days ago
Alice P Laflamme, OD Optometrist Medicare: Medicare Enrolled Practice Location: 3204 Tower Oaks Blvd Ste 300, Rockville, MD 20852 Phone: 301-231-5088 | |
Shady Grove Eye & Vision Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 15200 Shady Grove Rd, Suite 100, Rockville, MD 20850 Phone: 301-670-1212 Fax: 301-216-9692 | |
Pioneer Optical Company Optometrist Medicare: Not Enrolled in Medicare Practice Location: 50 W Edmonston Dr Ste 103, Rockville, MD 20852 Phone: 301-251-6735 | |
Howard Budner & Associates O.d. P.a Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4110 Aspen Hill Rd, 300, Rockville, MD 20853 Phone: 301-871-0180 Fax: 301-871-0179 | |
Sheila Wood, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11802 Rockville Pike Ste B, Rockville, MD 20852 Phone: 301-770-7780 Fax: 301-770-1433 | |
Ms. Rosa Nilo Dastrange, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 9850 Key West Ave, Rockville, MD 20850 Phone: 240-314-0160 |